A certificate of analysis (CoA) is a document that manufacturers create that verifies the products they manufacture conform to the customer requirements. This document helps ensure the customers know what product they are receiving and that it adheres to the specific parameters and targets. 

This document reports the quality assessment of the production lot and helps assure the customer the product they receive meets the desired quality standards. This is particularly useful in research, pharmaceutical, and biologics markets. Most of the products are produced in batches, as each batch or lot released needs to be under quality assessments to ensure the product’s purity, safety, and potency (if applicable). The parameters of each product and assessment vary depending on the manufacturer’s preference. A certificate of analysis must include: 

  • Supplier information: including the name, address, and contact information
  • Material Identification: this section identifies the verified material and usually contains lot numbers, product codes, and descriptions. 
  • Conformity evidence: specific information on the material is included in this section, such as characteristics, test results, and any customer requests. 
  • Signature: a signature indicating the evidence was reviewed and qualified by the product inspector is necessary. 

While CoAs are important, it is crucial that manufacturers do not rely solely on them. Given the complexity of outsourcing and supplier management, it’s essential to trust the information given on the CoA but to verify it. In general, this is done through verification of the supplier. 

A systematic approach to verifying supplier data is essential in any regulated industry. Pharmaceutical companies need to test the identity of incoming APIs and ingredients to confirm the supplier CoAs. The CoA is only one factor of many that impact verification of the quality of the product. A comprehensive quality system is important to any manufacturer since they may fail to consider the importance of document control, data review, and auditing. Not only can these processes help reduce the risk of data integrity failures as a cause of inadequate training, but they can also help communicate with the supplier.  Raw materials are vital to producing a high-quality end product. As such, it’s important to verify the CoA provided with any raw material and complete supplier verification. EMMA International has extensive knowledge and experience helping manufacturers verify their suppliers to produce quality and safe end products. For more information, contact EMMA International by phone at 248-987-4497 or by email at info@emmainternational.com

Emma International

Emma International

More Resources

The 10 Golden Rules for GMP Production – Part 1

The 10 Golden Rules for GMP Production – Part 1

Good Manufacturing Practices (GMP) is a system that consists of processes, procedures and documentation that ensures products are consistently produced and controlled according to set quality standards; for pharmaceutical production this is especially important. In general, there are 10 golden rules that apply in order to fulfill the GMP requirements. This article is part 1 of a 2-part series that discusses the first 5 rules and why they are important.
The eSTAR 510k

The eSTAR 510k

The voluntary eSTAR (electronic Submission Template And Resource) is a fillable portable document format (PDF) document that seeks to make 510(k) and De Novo submissions quicker and easier due to its automation from its form construction and autofill capability
Medical Device Reporting

Medical Device Reporting

Medical device reporting (MDR) is one of the post market surveillance tools used by the FDA to monitor medical devices’ performance post release (21 CFR part 803)

Ready to learn more about working with us?

Pin It on Pinterest

Share This